Sign in
4

Changes in Ownership

Olema Oncology, Inc. Filed Acc 0001749432-26-000004

CHIEF LEGAL OFFICER sold 40,000 shares at an average $23.79 ($951,503)

  • CHIEF LEGAL OFFICER acquired 40,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mitchell Shawnte CHIEF LEGAL OFFICER 2026-03-03 Option exercise +15,000 $4.37 $65,550 15,000 D: show line 1 in the form
Mitchell Shawnte CHIEF LEGAL OFFICER 2026-03-03 Sale −15,000 $23.01 $345,150 0 D: show line 2 in the form
Mitchell Shawnte CHIEF LEGAL OFFICER 2026-03-04 Option exercise +25,000 $4.37 $109,250 25,000 D: show line 3 in the form
Mitchell Shawnte CHIEF LEGAL OFFICER 2026-03-04 Sale −24,767 $24.25 $600,600 233 D: show line 4 in the form
Mitchell Shawnte CHIEF LEGAL OFFICER 2026-03-04 Sale −233 $24.69 $5,753 0 D: show line 5 in the form
Open-market sales · 40,000 sh · avg $23.79 · $951,503

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mitchell Shawnte CHIEF LEGAL OFFICER 2026-03-03 Option exercise · Stock Option (Right to Buy) −15,000 435,000 D: show line 6 in the form
Mitchell Shawnte CHIEF LEGAL OFFICER 2026-03-04 Option exercise · Stock Option (Right to Buy) −25,000 410,000 D: show line 7 in the form
Loading xslF345X05/form4-03052026_080301.xml…